Pharmaceutical preparations company · DE · FY ends Jul · Revenue $1M · -3050.04% margin · -$28M FCF
The business is unprofitable at the operating level (-3179.83% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 44.0% YoY with margins expanding 12931.2pp.
Negative free cash flow of -$19M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$1M
▲ +44.0% YoY
Net Income (TTM)
-$33M
▲ +11.3% YoY
Op. Margin
-3050.04%
▲ +12931.2pp YoY
ROIC
-32.68%
▲ +62.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$28M
▼ -138.2% YoY
Op. Cash Flow (TTM)
-$28M
▼ -142.6% YoY
Net Debt
-$38M
Net Cash Position
Cash & Equiv.
$38M
5Y CAGR: -28.5%
Continue Research